Table 1 Baseline characteristics
|  | All Cohort | NER ≤ 26.4 | NER > 26.4 | P-value |
|---|---|---|---|---|
Age (median, IQR) | 60.5 (54–69) | 62 (54–69) | 58 (53–70) | 0.32 |
Age ≤ 60.5 (%) | 55 (50) | 23 (42) | 32 (58) | 0.08 |
Age > 60.5 (%) | 55 (50) | 32 (58) | 23 (42) | |
Race (%) | ||||
 White | 94 (85.5) | 44 (47) | 50 (53) | 0.28 |
 Non-White | 12 (10.9) | 8 (67) | 4 (33) |  |
 Unknown | 4 (3.6) | 3 (75) | 1 (25) |  |
Sex (%) | ||||
 Male | 84 (76) | 43 (51) | 41 (49) | 0.65 |
 Female | 26 (24) | 12 (46) | 14 (54) |  |
IMDC (%) | ||||
 Favorable | 18 (16) | 11 (61) | 7 (39) | 0.33 |
 Intermediate | 73 (66) | 37 (51) | 36 (49) |  |
 Poor | 19 (17) | 7 (37) | 12 (63) |  |
Prior systemic treatment (%) | ||||
 Yes | 28 (25) | 11 (39) | 17 (61) | 0.19 |
 No | 82 (75) | 44 (54) | 38 (46) |  |